James M. Stockman Cancer Institute

1562 Oppossumtown Pike
Frederick, Maryland 21702

We've found

2 trials

at this facility

Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Frederick, MD

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Frederick, MD

Use our guide to learn which trials are right for you!